University of Iowa Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • University of Iowa Pharmaceuticals's estimated annual revenue is currently $51.9M per year.(i)
  • University of Iowa Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • University of Iowa Pharmaceuticals has 258 Employees.(i)
  • University of Iowa Pharmaceuticals grew their employee count by -1% last year.

University of Iowa Pharmaceuticals's People

NameTitleEmail/Phone
1
Director Sterile ProductsReveal Email/Phone
2
Director Pre-formulation and Formulation DevelopmentReveal Email/Phone
3
Managing DirectorReveal Email/Phone
4
Director Engineering and FacilitiesReveal Email/Phone
5
Project ManagerReveal Email/Phone
6
Project ManagerReveal Email/Phone
7
Program ManagerReveal Email/Phone
8
Manufacturing Quality ManagerReveal Email/Phone
9
ProfessorReveal Email/Phone
10
Advanced Practice NurseReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$28.4M5733%$75.8MN/A
#2
$1.2M6-73%N/AN/A
#3
$26.3M1313%N/AN/A
#4
$33.4M1662%N/AN/A
#5
$1073.9M53438%N/AN/A
#6
$9M4510%N/AN/A
#7
$20.5M10252%N/AN/A
#8
$20.1M10037%N/AN/A
#9
$9.2M4610%N/AN/A
#10
$3M15-56%N/AN/A
Add Company

What Is University of Iowa Pharmaceuticals?

University of Iowa Pharmaceuticals (UIP) is the largest and most experienced university-affiliated FDA-registered pharmaceutical manufacturing facility in the United States. UIP has been developing formulations, manufacturing products, and conducting analytical testing in compliance with cGMPs for almost 40 years. During the past 5 years UIP has manufactured over 1100 batches of product for over 100 different sponsors. UIP serves a broad spectrum of clients of all sizes in the pharmaceutical and biotechnology industries and has performed work for pharmaceutical companies throughout the United States and the world. Additionally, UIP has performed work for numerous government agencies, including the National Cancer Institute, the Centers for Disease Control, and the National Institutes of Health. UIP is capable of producing most types of pharmaceutical dosage forms. These dosage forms include sterile injectable solutions; sterile lyophilized (freeze-dried) powders; topical and oral solutions, emulsions, and suspensions; tablets (uncoated and film or functional coated); and hard gelatin capsules (powder or hot melt filled). UIP is compliant with 21 CFR parts 11, 210, and 211, licensed by the Drug Enforcement Agency (DEA) to handle controlled substances (Schedules I - V) and capable of handling potent/cytotoxic materials. UIP has produced numerous products for use in the European Union (EU) and passed numerous Qualified Person (QP) audits. Formulation Development, Clinical Supply Manufacturing, Analytical Testing Services, Small Scale Commerical Manufacturing, Analytical Method Development and Validation, Stability Studies, Sterile Filling, API Release Testing, Tablets and Capsules, Lyophilization

keywords:N/A

N/A

Total Funding

258

Number of Employees

$51.9M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

University of Iowa Pharmaceuticals News

2022-03-30 - Here’s the Republican senator that Big Pharma is betting on

In 2019, when the Senate Finance Committee considered a drug pricing bill crafted by Sen. Chuck Grassley (R-Iowa) and Sen. Ron Wyden (D-Ore.),...

2022-03-22 - Big Pharma Is Betting on Bigger Political Ambitions From Sen. Tim Scott

Scott was the top recipient of pharma campaign cash in Congress during ... University, points to factors beyond his stances on pharma issues...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$99.1M317N/AN/A
#2
$35M3274%N/A
#3
$76.5M340N/AN/A
#4
$15M3475%N/A
#5
$140.5M3484%N/A